 |
Paclitaxel protein-bound particles for injection suspension |
|---|---|
| Trade Name | Abraxane |
| Orphan Indication | Metastatic Melanoma |
| USA Market Approval | USA |
| USA Designation Date | 2009-10-01 00:00:00 |
| Sponsor | Celgene Corporation;400 Connell Drive, Suite 7000;Berkeley Heights, New Jersey, 07922 |
